Shortening of cardiac action potentials in endotoxic shock in guinea pigs is caused by an increase in nitric oxide activity and activation of the adenosine triphosphate-sensitive potassium channel

被引:30
作者
Chen, CC
Lin, YC
Chen, SA
Luk, HN
Ding, PYA
Chang, MS
Chiang, CE
机构
[1] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan
[3] Natl Yang Ming Univ, Taipei 112, Taiwan
[4] Show Chwan Mem Hosp, Dept Med, Changhua, Taiwan
[5] China Med Coll Hosp, Dept Med, Taichung, Taiwan
关键词
cardiac; action potential; endotoxic; shock; nitric oxide; adenosine triphosphate-sensitive potassium channel; guinea pig; lipopolysaccharide; cyclic guanosine monophosphate; micropipette; nitrate;
D O I
10.1097/00003246-200006000-00003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To investigate the roles of nitric oxide and adenosine triphosphate (ATP)-sensitive potassium channels (KATP) in the shortening of cardiac action potential in endotoxic shock. Design: Prospective animal study with concurrent controls. Setting: University animal research laboratory. Subjects: Adult Hartley guinea pigs, weighing 300-400 g. Interventions: Guinea pigs were anesthetized and mechanically ventilated far 6 hrs. Lipopolysaccharide (LPS) or saline (sham group) were given intravenously. Drug effects were examined at the end of 6 hrs. Measurements and Main Results:Plasma nitrate concentration was measured hourly, while guanosine 3',5'-cyclic monophosphate (cGMP) content and action potential duration at 90% of repolarization (APD(90)) of papillary muscle were examined every 2 hrs in Be 6-hr endotoxemia in both the sham and the LPS-treated groups. The basal levels of these three variables showed no difference in the two groups. In the sham group, these variables did not change significantly (n = 14 for plasma nitrate determination; n = 5 for cGMP content measurement; n = 5-14 for APD(90) measurement; all p > .05). But in the LPS-treated group, both plasma nitrate concentration and cGMP content of papillary muscle showed time-dependent increases and they were significantly higher than those in the sham group (at the 6th hr, plasma nitrate: 42.6 +/- 7.7 vs. 21.8 +/- 3.1 mu mol/L, both n = 14, p < .01; cGMP: 1.52 +/- 0.15 vs. 0.73 +/- 0.08 pmol/mg protein, both n = 5, p < .01). In contrast APD(90) revealed a time-dependent decrease compared with that in the sham group (at the 6th hr, 137.1 +/- 5.2 vs. 188.2 +/- 4.8 msecs, both n = 14, p < .001). In the following 60-min in vitro recording of action potentials after the end of 6-hr endotoxemia, the shortened APD(90) in the LPS-heated group did not recover and remained shorter compared with that in the sham group, in which the APD(90) showed no significant changes (at the 60th min, 165.1 +/- 5.7 vs. 200.2 +/- 3.8 msecs, each n = 14 p < .01). However, in the presence of glibenclamide, a specific KATP blocker (100 mu mol/L; n = 10), the APD(90) could be reversed almost completely to the same value as that in the sham group (n = 14) (196.6 +/- 3.5 vs. 200.2 +/- 38 msecs; p > .05), despite glibenclamide having no effect on the APD(90) in the sham group. In the LPS-treated group, NG-nitro-L-arginine methyl ester (1 mmol/L; n = 4), methylene blue (10 mu mol/L; n = 5), and aminoguanidine (100 mu mol/L; n = 4) significantly prolonged the shortened APD(90) (192.5 +/- 3.1, 195.0 +/- 3.3, and 176.5 +/- 3.3 msecs, respectively; p < .01, p < .01, and p < .05, respectively, compared with that without these agents, 165.1 +/- 5.7 msecs, n = 14). These agents had negligible effects an the APD(90) in the sham group (all p > .05). Furthermore, 8-bromoguanosine-3',5'-cyclic monophosphate (500 mu mol/L; n = 5) decreased APD in intact papillary muscle (mean reduction of APD(90), 13.5 +/- 3.5%, n = 5; p < .05), an effect abolished by pretreatment with glibenclamide (100 mu mol/L; n = 5) that did not have an effect by itself. Conclusions: In this experimental model, we provide reasonably convincing evidence to suggest that in endotoxic shock, an increase in nitric oxide activity may activate KATP, which plays a major role in the shortening of APD, presumably through a cGMP-dependent pathway.
引用
收藏
页码:1713 / 1720
页数:8
相关论文
共 67 条
  • [1] NITRIC-OXIDE - MEDIATOR, MURDERER, AND MEDICINE
    ANGGARD, E
    [J]. LANCET, 1994, 343 (8907) : 1199 - 1206
  • [2] INDUCTION OF NO SYNTHASE IN RAT CARDIAC MICROVASCULAR ENDOTHELIAL-CELLS BY IL-1-BETA AND IFN-GAMMA
    BALLIGAND, JL
    UNGUREANULONGROIS, D
    SIMMONS, WW
    KOBZIK, L
    LOWENSTEIN, CJ
    LAMAS, S
    KELLY, RA
    SMITH, TW
    MICHEL, T
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (03): : H1293 - H1303
  • [3] Nitric oxide synthases and cardiac muscle - Autocrine and paracrine influences
    Balligand, JL
    Cannon, PJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) : 1846 - 1858
  • [4] ABNORMAL CONTRACTILE FUNCTION DUE TO INDUCTION OF NITRIC-OXIDE SYNTHESIS IN RAT CARDIAC MYOCYTES FOLLOWS EXPOSURE TO ACTIVATED MACROPHAGE-CONDITIONED MEDIUM
    BALLIGAND, JL
    UNGUREANU, D
    KELLY, RA
    KOBZIK, L
    PIMENTAL, D
    MICHEL, T
    SMITH, TW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) : 2314 - 2319
  • [5] BALLIGAND JL, 1994, J BIOL CHEM, V269, P27580
  • [6] NITRIC OXIDE-DEPENDENT PARASYMPATHETIC SIGNALING IS DUE TO ACTIVATION OF CONSTITUTIVE ENDOTHELIAL (TYPE-III) NITRIC-OXIDE SYNTHASE IN CARDIAC MYOCYTES
    BALLIGAND, JL
    KOBZIK, L
    HAN, XQ
    KAYE, DM
    BELHASSEN, L
    OHARA, DS
    KELLY, RA
    SMITH, TW
    MICHEL, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14582 - 14586
  • [7] NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE
    BOLOTINA, VM
    NAJIBI, S
    PALACINO, JJ
    PAGANO, PJ
    COHEN, RA
    [J]. NATURE, 1994, 368 (6474) : 850 - 853
  • [8] NITRIC-OXIDE PRODUCTION WITHIN CARDIAC MYOCYTES REDUCES THEIR CONTRACTILITY IN ENDOTOXEMIA
    BRADY, AJB
    POOLEWILSON, PA
    HARDING, SE
    WARREN, JB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (06): : H1963 - H1966
  • [9] Brady AJB, 1993, AM J PHYSIOL, P176
  • [10] Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
    Calderone, A
    Thaik, CM
    Takahashi, N
    Chang, DLF
    Colucci, WS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 812 - 818